IRIS
CASTELLANI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 745
AS - Asia 22
SA - Sud America 1
Totale 768
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 745
CN - Cina 20
SG - Singapore 2
BR - Brasile 1
Totale 768
Salva come PNG Salva come JPEG
Città #
Genoa 564
Vado Ligure 95
Rapallo 55
Genova 29
Beijing 9
Bordighera 2
Singapore 1
Torres 1
Totale 756
Salva come PNG Salva come JPEG
Nome #
A case of interference in testosterone, DHEA-S and progesterone measurements by second generation immunoassays 121
The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs 100
Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review 74
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background 74
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method 63
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study 52
Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators 46
Primary Lung Tumors in Children: Insights from a Single-Center Case Series 45
Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica 44
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD 43
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators 41
Quantification of Ivacaftor, Tezacaftor and Elexacaftor in plasma of cystic fibrosis patients treated with Kaftrio by a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method” 39
One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study 36
In silico, in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators 10
Totale 788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.322
article - articoli 2.983
book - libri 0
conference - conferenze 339
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202234 0 0 0 0 2 1 0 3 3 3 18 4
2022/202369 4 6 0 5 9 7 4 5 15 0 13 1
2023/202474 3 4 5 8 11 15 4 4 0 2 8 10
2024/2025403 8 20 15 12 15 37 18 93 47 36 47 55
2025/2026208 98 24 38 48 0 0 0 0 0 0 0 0
Totale 788